CFO4Life Group’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,430
| Closed | -$218K | – | 239 |
|
|
2025
Q1 | $218K | Sell |
2,430
-973
| -29% | -$87.4K | 0.04% | 193 |
|
|
2024
Q4 | $272K | Sell |
3,403
-95
| -3% | -$7.59K | 0.05% | 166 |
|
|
2024
Q3 | $315K | Buy |
3,498
+23
| +0.7% | +$2.07K | 0.06% | 156 |
|
|
2024
Q2 | $274K | Sell |
3,475
-660
| -16% | -$52K | 0.05% | 156 |
|
|
2024
Q1 | $360K | Buy |
4,135
+1,203
| +41% | +$105K | 0.07% | 137 |
|
|
2023
Q4 | $242K | Sell |
2,932
-555
| -16% | -$45.7K | 0.05% | 153 |
|
|
2023
Q3 | $273K | Sell |
3,487
-84
| -2% | -$6.58K | 0.06% | 128 |
|
|
2023
Q2 | $315K | Sell |
3,571
-883
| -20% | -$77.8K | 0.07% | 130 |
|
|
2023
Q1 | $359K | Buy |
4,454
+1,039
| +30% | +$83.8K | 0.08% | 114 |
|
|
2022
Q4 | $265K | Buy |
+3,415
| New | +$265K | 0.06% | 144 |
|
|
2022
Q2 | – | Sell |
-2,376
| Closed | -$264K | – | 161 |
|
|
2022
Q1 | $264K | Buy |
2,376
+293
| +14% | +$32.6K | 0.06% | 127 |
|
|
2021
Q4 | $216K | Sell |
2,083
-161
| -7% | -$16.7K | 0.04% | 143 |
|
|
2021
Q3 | $281K | Buy |
2,244
+511
| +29% | +$64K | 0.07% | 113 |
|
|
2021
Q2 | $215K | Sell |
1,733
-192
| -10% | -$23.8K | 0.05% | 132 |
|
|
2021
Q1 | $227K | Buy |
1,925
+202
| +12% | +$23.8K | 0.06% | 133 |
|
|
2020
Q4 | $202K | Buy |
+1,723
| New | +$202K | 0.06% | 132 |
|
|
2020
Q1 | – | Sell |
-2,068
| Closed | -$235K | – | 129 |
|
|
2019
Q4 | $235K | Buy |
2,068
+46
| +2% | +$5.23K | 0.1% | 107 |
|
|
2019
Q3 | $220K | Buy |
+2,022
| New | +$220K | 0.1% | 107 |
|